Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 3
1941 1
1943 1
1944 2
1946 6
1947 2
1948 1
1949 1
1950 2
1951 3
1952 4
1953 3
1954 2
1955 1
1956 1
1957 4
1958 3
1959 3
1960 4
1961 2
1962 4
1963 6
1964 10
1965 6
1966 5
1967 4
1968 4
1970 3
1971 7
1972 3
1973 7
1974 5
1975 3
1976 7
1977 3
1978 7
1979 9
1980 4
1981 9
1982 3
1983 4
1984 2
1985 7
1986 1
1987 3
1988 7
1989 7
1990 8
1991 14
1992 12
1993 13
1994 15
1995 6
1996 14
1997 15
1998 15
1999 12
2000 13
2001 18
2002 21
2003 22
2004 19
2005 21
2006 26
2007 21
2008 22
2009 13
2010 14
2011 19
2012 25
2013 19
2014 19
2015 18
2016 19
2017 29
2018 33
2019 28
2020 43
2021 54
2022 50
2023 39

Text availability

Article attribute

Article type

Publication date

Search Results

864 results

Results by year

Filters applied: . Clear all
Page 1
Major depressive disorder.
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Otte C, et al. Among authors: gold sm. Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65. Nat Rev Dis Primers. 2016. PMID: 27629598 Review.
Comorbid depression in medical diseases.
Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, Steptoe A, Whooley MA, Otte C. Gold SM, et al. Nat Rev Dis Primers. 2020 Aug 20;6(1):69. doi: 10.1038/s41572-020-0200-2. Nat Rev Dis Primers. 2020. PMID: 32820163 Review.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Sforzini L, Worrell C, Kose M, Anderson IM, Aouizerate B, Arolt V, Bauer M, Baune BT, Blier P, Cleare AJ, Cowen PJ, Dinan TG, Fagiolini A, Ferrier IN, Hegerl U, Krystal AD, Leboyer M, McAllister-Williams RH, McIntyre RS, Meyer-Lindenberg A, Miller AH, Nemeroff CB, Normann C, Nutt D, Pallanti S, Pani L, Penninx BWJH, Schatzberg AF, Shelton RC, Yatham LN, Young AH, Zahn R, Aislaitner G, Butlen-Ducuing F, Fletcher C, Haberkamp M, Laughren T, Mäntylä FL, Schruers K, Thomson A, Arteaga-Henríquez G, Benedetti F, Cash-Gibson L, Chae WR, De Smedt H, Gold SM, Hoogendijk WJG, Mondragón VJ, Maron E, Martynowicz J, Melloni E, Otte C, Perez-Fuentes G, Poletti S, Schmidt ME, van de Ketterij E, Woo K, Flossbach Y, Ramos-Quiroga JA, Savitz AJ, Pariante CM. Sforzini L, et al. Among authors: gold sm. Mol Psychiatry. 2022 Mar;27(3):1286-1299. doi: 10.1038/s41380-021-01381-x. Epub 2021 Dec 15. Mol Psychiatry. 2022. PMID: 34907394 Free PMC article. Review.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. Johnson AM, et al. Among authors: gold s. Am J Gastroenterol. 2023 Feb 1;118(2):317-328. doi: 10.14309/ajg.0000000000002047. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191274
Lymph node imaging in testicular cancer.
Hale GR, Teplitsky S, Truong H, Gold SA, Bloom JB, Agarwal PK. Hale GR, et al. Among authors: gold sa. Transl Androl Urol. 2018 Oct;7(5):864-874. doi: 10.21037/tau.2018.07.18. Transl Androl Urol. 2018. PMID: 30456189 Free PMC article. Review.
Voices of biotech leaders.
Bosley K, Casebourn C, Chan P, Chen J, Chen M, Church G, Cumbers J, de Wouters T, Dewey-Hagborg H, Duportet X, Ene-Obong A, Elizondo A, Farrar J, Gates B, Gatto F, Giwa S, Godec J, Gold S, LeProust E, Lunshof J, Martucci E, Heath MM, Mellad J, Oudova V, Oxman N, Regev A, Richardson S, Scott CT, Sherkow J, Sibener L, Tarragó T, Terry S, Venter JC, Wang S, Wickramasekara S, Yadi H, Yang L, Zhao B. Bosley K, et al. Among authors: gold s. Nat Biotechnol. 2021 Jun;39(6):654-660. doi: 10.1038/s41587-021-00941-4. Nat Biotechnol. 2021. PMID: 34113035 No abstract available.
Modern slavery risk assessment.
Gold S, Gutierrez-Huerter O G, Trautrims A. Gold S, et al. Nat Food. 2021 Sep;2(9):644-645. doi: 10.1038/s43016-021-00348-z. Nat Food. 2021. PMID: 37117462 No abstract available.
Immune signature of multiple sclerosis-associated depression.
Brasanac J, Ramien C, Gamradt S, Taenzer A, Glau L, Ritter K, Patas K, Agorastos A, Wiedemann K, Demiralay C, Fischer F, Otte C, Bellmann-Strobl J, Friese MA, Tolosa E, Paul F, Heesen C, Weygandt M, Gold SM. Brasanac J, et al. Among authors: gold sm. Brain Behav Immun. 2022 Feb;100:174-182. doi: 10.1016/j.bbi.2021.11.022. Epub 2021 Dec 1. Brain Behav Immun. 2022. PMID: 34863857
Legal obstacles to toxic chemical research.
Wagner WE, Gold SC. Wagner WE, et al. Among authors: gold sc. Science. 2022 Jan 14;375(6577):138-141. doi: 10.1126/science.abl4383. Epub 2022 Jan 13. Science. 2022. PMID: 35025638
864 results